Skip to main content
EU-Startups Funding· Rahul Raj·· 4 days agoTop DealsAI Score68

Amsterdam's VectorY Therapeutics raises €74.5M for ALS and neurodegenerative therapies

Amsterdam’s VectorY Therapeutics raises €74.5 million to tackle ALS and other neurodegenerative diseases

AI Overview

VectorY Therapeutics, an Amsterdam biotech, raised €74.5M ($83.5M) from new investors including Angelini Ventures.

Why it matters

The round shows which investors are backing AAV-delivered antibody therapies for ALS and Huntington's, and where the lead program stands in its Phase 1/2 trial.

Source:EU-Startups Funding · eu-startups.com

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing